Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06841081 · ClinicalTrials.gov registry record · NA
Super-Supporters - Virtual Care Technology Navigators
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 1,111
- Enrollment target
NCT06841081: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT06841081 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 1,111 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (21% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06841081, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,111 participants
- Enrollment target
Study Summary
The Super-Supporter Program is designed to provide pre-visit support to patients who are at risk of not being able to participate in Virtual Care modalities (specifically, Clinical Video Visits). Patient technology navigators (Super-Supporters) will reach out before video visits and help the patient connect more easily and successfully with their providers in Virtual Care appointments.
Primary Outcome
Data will be collected from electronic health record review
Interventions
- OTHER Enhanced Usual Care
- OTHER Super Supporter Support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,111 participants |
| Start Date | 2021-11-01 |
| Est. Completion | 2025-01-21 |
| Phase | NA |
What the finished NCT06841081 record still lists
NCT06841081 is an interventional study that assigns participants to a tested intervention. Its 1,111 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (21% lower).
The record links to 0 conditions, and to 2 interventions - of which Enhanced Usual Care is the first listed.
NCT06841081 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06841081 about?
NCT06841081 is a clinical study titled "Super-Supporters - Virtual Care Technology Navigators". The Super-Supporter Program is designed to provide pre-visit support to patients who are at risk of not being able to participate in Virtual Care modalities (specifically, Clinical Video Visits). Patient technology navigators (Super-Supporters) will reach out before video visits and help the patient...
What is the current status of trial NCT06841081?
This trial is currently completed. It is a NA study. The enrollment target is 1,111 participants. The study started on 2021-11-01. Estimated completion is 2025-01-21.
What interventions are being tested in trial NCT06841081?
The interventions under investigation include: Enhanced Usual Care (OTHER), Super Supporter Support (OTHER).
Who is sponsoring clinical trial NCT06841081?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06841081's enrollment target sits among peer trials
1,111 93rd of 2000 higher than 1,908 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02140255 · 1,120 participants · Phase 1
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
- NCT06618534 · 1,120 participants · Phase 2
Azithromycin for Meningococcal Carriage
- NCT07164131 · 1,120 participants · Phase 4
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
- NCT05691478 · 1,122 participants · Phase 2
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI